Helius Medical Technologies (NASDAQ:HSDT) Posts Quarterly Earnings Results, Misses Expectations By $0.09 EPS

Helius Medical Technologies (NASDAQ:HSDT) released its earnings results on Tuesday. The company reported ($1.03) EPS for the quarter, missing the consensus estimate of ($0.94) by ($0.09), Zacks reports. Helius Medical Technologies had a negative return on equity of 244.82% and a negative net margin of 1,764.74%.

Helius Medical Technologies Stock Up 4.2 %

Helius Medical Technologies stock traded up $0.02 during mid-day trading on Tuesday, hitting $0.41. The company’s stock had a trading volume of 15,829 shares, compared to its average volume of 1,405,017. The stock’s fifty day moving average price is $0.57 and its two-hundred day moving average price is $0.60. The stock has a market capitalization of $1.53 million, a P/E ratio of -0.07 and a beta of 1.62. Helius Medical Technologies has a twelve month low of $0.37 and a twelve month high of $7.19.

Helius Medical Technologies Company Profile

Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.